COVID - 19 Vaccination Update - Day 465 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 40 Second

Posted On: 25 APR 2022 8:05 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 187.92 Crore (1,87,92,85,675) today. More than 20 lakh (20,55,837) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10404813
	2^nd Dose	10012984
	Precaution Dose	4714609
FLWs	1^st Dose	18415105
	2^nd Dose	17533457
	Precaution Dose	7399347
Age Group 12-14 years	1^st Dose	27035118
	2^nd Dose	3660613
Age Group 15-18 years	1^st Dose	58197765
	2^nd Dose	41542687
Age Group 18-44 years	1^st Dose	555528685
	2^nd Dose	475987616
	Precaution Dose	102057
Age Group 45-59 years	1^st Dose	202889400
	2^nd Dose	187479124
	Precaution Dose	362853
Over 60 years	1^st Dose	126843176
	2^nd Dose	116793678
	Precaution Dose	14382588
Cumulative 1^st dose administered		999314062
Cumulative 2^nd dose administered		853010159
Precaution Dose		26961454
Total		1879285675

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 25^th April, 2022 (465^th Day)
HCWs	1^st Dose	44
	2^nd Dose	739
	Precaution Dose	16114
FLWs	1^st Dose	81
	2^nd Dose	952
	Precaution Dose	37505
Age Group 12-14 years	1^st Dose	371616
	2^nd Dose	673083
Age Group 15-18 years	1^st Dose	45003
	2^nd Dose	144598
Age Group 18-44 years	1^st Dose	35143
	2^nd Dose	397551
	Precaution Dose	9662
Age Group 45-59 years	1^st Dose	4578
	2^nd Dose	81159
	Precaution Dose	37300
Over 60 years	1^st Dose	3388
	2^nd Dose	51551
	Precaution Dose	145770
Cumulative 1^st dose administered		459853
Cumulative 2^nd dose administered		1349633
Precaution Dose		246351
Total		2055837

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.